Purpose of the study

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19).

The purpose of this study program is to evaluate the effectiveness and safety of the study drug in adults with confirmed Coronavirus infection (COVID-19/ SARS-COV-2)   and in people who are at high risk of Coronavirus infection (COVID-19/ SARS-COV-2).

Who may participate in this study?

You may qualify for this research study if the following applies to you:

• You are at least 18 years old  
• You have tested positive for/ you are infected with Coronavirus (COVID-19/ SARS-CoV-2) 
• You have COVID-19 symptoms, such as: fever, dry cough, shortness of breath, sore throat etc.
• You are currently not hospitalized AND you have not been previously hospitalized due to COVID-19

OR

• You are at least 18 years old  
• You are currently living in the same household as a person who was diagnosed with Coronavirus (COVID-19) within the last 96 hours (4 days)
• You have never been diagnosed with Coronavirus Infection (COVID-19/ SARS-CoV-2)

There are other eligibility requirements. A final decision on whether this research study might be suitable for you will be made after you complete the online and phone questionnaire and speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.

Additional Information

If you participate in this study, you will be asked to stay at the research site for a duration of approximately 1-7 days. The study team will discuss the duration of your stay during your first visit at the research site. 

Reimbursement

You may receive reimbursement for expenses related to study participation. Information will be provided by the study doctor.